By Andrew Silver and Patrick Wingrove SHANGHAI/LONDON, Nov 12 (Reuters) – Eli Lilly on Thursday became the first drugmaker to win approval in China for a GLP-1 weight-loss pill, giving it an early
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Infantino plays down security fears over U17 World Cup, refuses questions on presidency
VIDEO SHOWS: FIFA PRESIDENT GIANNI INFANTINO TOURING FACILITIES FOR THE U17 WORLD CUP / SOUNDBITES…
BRIEF-Ofra Strauss Joins TopGum's Board Of Directors
Nov 12 (Reuters) - Top Gum Industries Ltd: * OFRA STRAUSS JOINS TOPGUM'S BOARD OF…
Speaker Johnson says Congress developing consensus on limiting chip exports to China
WASHINGTON, Nov 12 (Reuters) - US House Speaker Mike Johnson said on Thursday there was…
